A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors.
about
Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationshipsHigh-dimensional propensity score adjustment in studies of treatment effects using health care claims dataSafety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary interventionInstrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance.Developments in post-marketing comparative effectiveness researchIncreasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial resultsUnderstanding secondary databases: a commentary on "Sources of bias for health state characteristics in secondary databases"Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity.Prescriber preference for a particular tumour necrosis factor antagonist drug and treatment discontinuation: population-based cohortImpact of drug policy on regional trends in ezetimibe useAntipsychotic prescribing: do conflict of interest policies make a difference?New chronic disease medication prescribing by nurse practitioners, physician assistants, and primary care physicians: a cohort study.Role of disease risk scores in comparative effectiveness research with emerging therapiesA review of accessibility of administrative healthcare databases in the Asia-Pacific region.External adjustment sensitivity analysis for unmeasured confounding: an application to coronary stent outcomes, Pennsylvania 2004-2008.Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics.Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory ModelsPhysician prescribing behavior and its impact on patient-level outcomes.Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variableHow quickly do physicians adopt new drugs? The case of second-generation antipsychotics.Changes in physician antipsychotic prescribing preferences, 2002-2007.Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines.A technical infrastructure to conduct randomized database studies facilitated by a general practice research database.Physician Preferences and Variations in Prescription of Biologic Drugs for Rheumatoid Arthritis: A Register-Based Study of 4,010 Patients in Sweden.Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development.High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications.Changing patterns of use of osteoporosis medications in the years after launch: implications for comparative effectiveness research.Patterns and predictors of physician adoption of new cardiovascular drugs.Comparing adherence to two different HIV antiretroviral regimens: an instrumental variable analysis.Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results.
P2860
Q33428425-E46866F2-8E64-439A-901E-46932E043641Q33457966-41867361-9B35-4C14-84D2-3E688BAF118BQ33701953-485223EE-C92A-4694-AF1D-B7335BB576FCQ33914708-2477019F-159F-41F0-95F8-FC968FBD43DEQ34001867-6E1F5940-A9A5-4159-95D9-BC3DB6F7FDC7Q34001872-7572077B-EF71-4E0B-B475-5283AC4E4A37Q34001913-D48FC00F-BACD-4020-A01D-D7DAC51331E3Q34033597-BFD0EDB7-A220-4B8A-8D4E-1D396E73A108Q34264302-7E91E4A1-A40B-4BD9-8C22-7B0C1B06EE4CQ34462245-DBBF61EE-7F82-4744-85A8-469C95D97B57Q35180226-A83ED775-7804-467E-B93F-A83A9740EF05Q36087596-BA7A1341-E9CB-4080-ACEE-682721508AC3Q36266471-ADE55B48-EF2E-423D-A2FC-6E058AAE249FQ36714685-5C91CAB8-14C2-4125-9030-B71672421CBAQ36925442-9FF754EF-57F6-474E-8CAB-3F68C2CA26F0Q36926903-9A806343-3666-44D1-A0D2-09DFB95C9658Q37004184-FF9D2389-28CA-4E98-8C6C-7127F345F99CQ37195505-B5FBC7A7-178B-4FEB-A575-CCA84F5BA43FQ37275612-F0DFFFF0-7C0F-4D05-AD03-4107857996BEQ37535043-15BD32A5-C680-4BC9-9636-299929C1AE8DQ37626797-76E8B1BA-BE9C-4553-BEAB-EB0E8EDD22C9Q38429068-0C8563ED-94B8-4522-8689-8ADFDB801654Q38456939-BE02DB8F-39A6-49AF-A8AA-DC306F437DBFQ38533964-714D278C-0AB0-422C-A28C-619244F87C4EQ43430988-D378AB68-8C70-458A-B19D-86810A7E143AQ43701143-1DA45EBA-2EF3-4863-AA5B-FD142BF88449Q46262689-2C38C7FF-F7A5-4049-A3CE-05955211653CQ46590970-292D18BE-0B8D-40E7-BF4A-88432FC9C6EDQ48631709-81A50890-D77A-49F3-BAEB-C19277A66552Q53059318-6AD34804-4B05-469F-AE57-DA6B4A9E7A1C
P2860
A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A Medicare database review fou ...... riptions for COX-2 inhibitors.
@ast
A Medicare database review fou ...... riptions for COX-2 inhibitors.
@en
type
label
A Medicare database review fou ...... riptions for COX-2 inhibitors.
@ast
A Medicare database review fou ...... riptions for COX-2 inhibitors.
@en
prefLabel
A Medicare database review fou ...... riptions for COX-2 inhibitors.
@ast
A Medicare database review fou ...... riptions for COX-2 inhibitors.
@en
P2093
P1476
A Medicare database review fou ...... riptions for COX-2 inhibitors.
@en
P2093
Daniel H Solomon
Jerry Avorn
Robert J Glynn
Sebastian Schneeweiss
P304
P356
10.1016/J.JCLINEPI.2004.06.002
P577
2005-01-01T00:00:00Z